Pfizer Asks FDA to Fully Approve Its Covid-19 Pill

In order to make the Covid-19 antiviral pill commercially available, Pfizer Inc. has requested the Food and Drug Administration for complete approval.

Pfizer announced on Thursday that the submission had been made. Before making a judgment, the FDA normally has 60 days to receive the application and up to 10 months to perform the review.

Paxlovid is a medication that Pfizer has been providing to the federal government as part of an emergency use authorisation up until this point.

The distribution of the medicines has since been overseen by the federal government.

If the FDA approves, Pfizer could start marketing the medication like it does with the majority of its pharmaceuticals.

Pfizer sells using advertising and through middlemen who give it to pharmacies and other customers.

Click Here

Follow For More Updates